-
-
Call more information
660-596-2224 -
Although inconsistencies among anesthesiologists have been demonstrated in the American Society of Anesthesiologists (ASA) physical status classification system, one study from the State University of New York (SUNY) Downstate Medical Center, in New York City, has found that agreement between anesthesiologists and nonanesthesiologists is exceedingly weak. These discrepancies are particularly evident in patients with higher […]
Read MoreHypertensive disorders in pregnancy (HDP) are associated with an increased risk of cardiomyopathy years after an affected pregnancy and regardless of hypertension severity, a large registry study involving one million Danish women shows. “The fact that we could drop the first 5 years after pregnancy and still see this risk was really fascinating,” senior author […]
Read MoreThe toll that opioid addiction has taken in the United States is staggering, said Jesse Theisen-Toupal, MD, from the Veterans Administration Medical Center in Washington, DC. “In 2000, there were 4400 opioid overdose-related deaths,” he reported here at the Society of Hospital Medicine 2016 Annual Meeting. “In 2013, there were 16,000.” Despite this crisis, some […]
Read MoreContrary to expectations, smoking and obesity do not appear to affect the efficacy of, or increase the infection rate related to, spinal cord stimulator implantation, a new study shows. “It’s very well known that smoking, for example, can increase the risk of infection and of complications in different types of major surgery, especially spinal surgery,” […]
Read MoreA peripherally acting oral μ-opioid receptor antagonist is superior to placebo in treating opioid-induced constipation (OIC) and doesn’t reduce the analgesic effect of opioids, a new phase 3 study shows. If approved, the new drug, naldemedine (Shionogi Inc), will provide another option for physicians and patients to treat OIC, which is common in patients taking […]
Read MoreAs opioid-related deaths across the country skyrocket, more and more state, national, and international groups are calling for widespread community access to naloxone, a drug that reverses opioid overdose. While naloxone has traditionally been administered in a hospital or medical setting by trained emergency responders, the drug is now available as a “take-home” product that […]
Read MoreWith more pain patients turning to medical marijuana (and recreational cannabis) to ease their discomfort, clinicians might want to consider issues pertaining to driving and working while under the influence. Gerald Aronoff, MD, medical director, Carolina Pain Associates, and medical director, North American Pain & Disability Group, Charlotte, North Carolina, doesn’t prescribe opiates to his […]
Read MoreA noninvasive, easy-to-administer sphenopalatine ganglion block relieves postdural puncture headache (PDPH) faster than an epidural blood patch in obstetric patients and has fewer adverse effects, new research shows. The block works so well in patients with PDPH that it should the considered the first line treatment in this population, said Preet Patel, MD, Department of […]
Read MoreAdding the atypical antipsychotic drug olanzapine to a patient’s therapeutic regimen might help ease their refractory pain, a new systematic review suggests. Although not US Food and Drug Administration (FDA)–approved for pain, and not traditionally considered an analgesic, olanzapine has the strongest evidence for pain control of all the atypical antipsychotics, according to the review. […]
Read MoreA patient was in a motor vehicle accident that shattered his right leg. He started taking morphine extended-release tablets (MS Contin, Purdue Pharma) at a dose of 100 mg up to three times daily with escalating doses over 4 years, but he still had persistent back and leg pain that he rated a 10 on […]
Read More